… MicroRNAs have emerged as critical regulators of cholesterol metabolism and promising
therapeutic targets for treating cardiometabolic disorders including atherosclerosis. Here, we …

… : molecular mechanisms underlying their actions and promising therapeutic targets [Abstract] …
: molecular mechanisms underlying their actions and promising therapeutic targets [Abstract…

… Thus, these preclinical studies show proof-of-principle that PlGF and VEGFR-1 are promising
therapeutic targets to treat angiogenesis and inflammation related disorders. Clinical trials …

… transcription factors that are emerging as promising therapeutic targets for limiting
atherosclerosis, an inflammatory disorder orchestrated by cytokines. The potent anti-atherogenic …

… endogenous tPA have both turned into promising therapeutic targets for the stroke patient. …
of pharmacotherapy can all help prevent atherosclerosis, the major culprit behind ischemic …

… LncRNAs may become promising therapeutic targets in endothelial dysfunction-related …
endothelial cells via inhibition of proinflammatory cytokines, platelet aggregation or cell adhesion …

… -activated receptor (PPAR)-γ, and can reduce cytokine-induced systemic inflammation to
prevent the progression of atherosclerotic plaques (65). Similarly, Oleoylethanolamide is an …

… treatment effectiveness and are promising therapeutic targets as part of multi-targeted
therapy. … vivax leads to disproportional organ-specific parasitaemia and what role the cytokine …

… activation, are promising therapeutic targets for tackling … the increased production of cytokines
by monocytes could be … clearance of cytokines might contribute to elevated cytokine levels …

… for cardiovascular disease and even promising therapeutic targets for its treatment. … The
secretion of MCP-1, a key pathological cytokine in vascular inflammation and atherosclerosis, …